- ►nih.gov AK Jha, GJ Kuperman, JM Teich, L Leape, B … - Journal of the American Medical Informatics …, 1998 - Am Med Inform Assoc Abstract Background: Adverse drug events (ADEs) are both common and costly. Most
hospitals identify ADEs using spontaneous reporting, but this approach lacks
sensitivity; chart review identifies more events but is expensive. Computer- ... Cited by 310 - Related articles - BL Direct - All 8 versions
DJ Cullen, DW Bates, SD Small, JB Cooper, … - The Joint Commission journal on quality improvement, 1995 - ncbi.nlm.nih.gov OBJECTIVES: The objectives of this study were 1) to determine the frequency with
which adverse drug events result in an incident report (IR) in hospitalized
patients; and 2) to determine if there were differences between quality ... Cited by 406 - Related articles
- ►theradoc.com [PDF] DC Classen, SL Pestonik, R Scott Evans, JF … - Obstetrical & Gynecological Survey, 1997 - journals.lww.com From January 1, 1990 to December 1993, 2,227 of the 92,574 patients admitted to
the LDS Hospital were treated for adverse drug events (2.43 adverse drug events
per 100 admissions). The authors examined the course of the ... Cited by 1068 - Related articles - BL Direct - All 8 versions
RS Evans, SL Pestotnik, DC Classen, SD Horn … - Annals of Pharmacotherapy, 1994 - theradoc.com Preventing Adverse Drug Effects drug or same class of drugs as previously noted
in the pa- tient's medical record, eg, penicillins or sulfonamides. However,
cross-allergenicity between different beta-lactam drugs was not evaluated. ... Cited by 132 - Related articles - All 4 versions
DW Bates, DJ Cullen, N Laird, LA Petersen, SD … - Jama, 1995 - Am Med Assoc OBJECTIVES--To assess incidence and preventability of adverse drug events (ADEs)
and potential ADEs. To analyze preventable events to develop prevention
strategies. DESIGN--Prospective cohort study. PARTICIPANTS--All 4031 adult ... Cited by 1506 - Related articles - BL Direct - All 4 versions
DW Bates, N Spell, DJ Cullen, E Burdick, N … - Jama, 1997 - Am Med Assoc OBJECTIVE: To assess the additional resource utilization associated with an
adverse drug event (ADE). DESIGN: Nested case-control study within a prospective
cohort study. PARTICIPANTS: The cohort included 4108 admissions to a ... Cited by 1053 - Related articles - BL Direct - All 7 versions
- ►nih.gov B Honigman, J Lee, J Rothschild, P Light, RM … - Journal of the American Medical Informatics …, 2001 - Am Med Inform Assoc Affiliations of the authors: University of Colorado Health Sciences Center,
Denver, Colorado (BH); Harvard Medical School, Boston, Massachusetts (JL, JR,
TY, DWB); Post-graduate Institute for Medicine, Englewood, Colorado (PL); ... Cited by 123 - Related articles - BL Direct - All 7 versions
JD Rozich, CR Haraden, RK Resar - Quality and safety in Health Care, 2003 - qshc.bmj.com Adverse drug events continue to be the single most frequent source of healthcare
mishaps, continually placing patients at risk of injury. This is not unexpected,
given that drug treatment is the most common medical intervention and ... Cited by 138 - Related articles - BL Direct - All 17 versions
DW Bates, DJ Cullen, N Laird, LA Petersen, SD … - Jama, 1995 - ptsafetyresearch.org Table 1.—Interrater Agreement on Incident Type, Preventability, and Severity
of Adverse Drug Events (ADEs) Table 2.—Numbers and Crude and Adjusted Rates of
Adverse Drug Events (ADEs) and Potential ADEs Judgment Agreement, %* к ... Cited by 373 - Related articles - BL Direct - All 3 versions
